The key benefits are reduced risk and immediate use of capital for critical projects and ongoing research funding. A big deal can also bring positive press to the TTO and university, a windfall for researchers, and a surge in disclosures among faculty. But the process of sealing a monetization deal is also wrought with its own risk and uncertainty. Without proper preparation and analysis, it can cost your millions and backfire into a faculty relations nightmare (witness the University of Georgia’s debacle with its Restasis monetization).
That’s why Technology Transfer Tactics recruited two veteran deal-makers to guide you through the process and ensure your analysis is thorough and your deal is optimal for your institution.
Please join Louis P. Berneman, Managing Director of Texelerate, LLC, and Christopher T. Cox, a partner in the New York City office of the Cahill law firm, for this high-level program:
When and How to Monetize Your IP
by Selling Your Royalty Stream
If you’re planning or even thinking about monetizing a royalty stream, you simply can’t afford to miss this critical session. You’ll get a detailed analysis of the advantages and disadvantages of a royalty interest sale, and our expert faculty will help you:
- Prepare you for the institutional decision making process:
- Threshold Considerations
- Preparatory Due Diligence
- Stakeholders’ Interests
- Review and Approval Process
- Selecting Advisors
- Review the key components of a monetization transaction:
- Most Active Investors (Buyers)
- Key Investment Criteria
- Valuation Issues
- Transaction Structure and Timing
- Due Diligence Process
- Transaction Documentation
Plus, you’ll get an overview of market trends and provide you with case study examples – and live Q&A to answer all your monetization questions
Your Expert Presenters:
Dr. Louis Berneman has undertaken research, given expert testimony, written published articles, and been a frequent speaker on various topics in university licensing trends and best practices, intellectual asset management, technology transfer, negotiation, valuation and economic development. From 1995 to 2005, he was the Managing Director of the Center for Technology Transfer and the Intellectual Property Administrator at the University of Pennsylvania. Dr. Berneman is a Past President of the Association of University Technology Managers and is a former officer and director (trustee) of the Licensing Executives Society (U.S. & Canada) and the LES Foundation. Dr. Berneman has founded technology-based entrepreneurial ventures and served on the boards of companies and industry organizations including the Pennsylvania Biotechnology Association and the Greater Philadelphia Venture Group.
Christopher Cox represents clients in a wide array of corporate and financial matters, with particular emphasis on mergers and acquisitions and corporate governance. He has represented public and private acquirers, targets, investment banks and private equity sponsors in connection with negotiated mergers and acquisitions, restructurings, joint ventures and proxy contests. He has also represented foreign and domestic entities in many aspects of cross-border business transactions. Chris counsels clients on a broad range of corporate, securities and business-related matters and matters affecting corporate policy and strategy, including directors’ duties and responsibilities and other aspects of corporate governance, disclosure issues, corporate compliance matters, issues related to Sarbanes-Oxley compliance and financing transactions. Chris has worked extensively in the pharmaceutical industry, representing clients in public and private mergers and acquisitions, joint ventures, restructurings and all aspects of corporate finance.